Abstract
Pretreatment with estradiol (20 mg IM) attenuated vasoreactivity to decreases in inspired PIO2 lowered baseline resistance measured under conditions of maximal vasodilation (PIO2 = 0 mm Hg), and appeared to increase prostaglandin release in isolated, blood-perfused lungs of juvenile female sheep. Indomethacin (40 μg/ml) inhibited prostaglandin release and restored hypoxic vasoreactivity in estrogen-treated lungs, but did not alter the estrogen-induced decrease in baseline resistance. These results suggest that estradiol enhanced the production of prostaglandins which secondarily attenuated hypoxic vasoreactivity. The estradiol-induced decrease in baseline resistance, however, must have been mediated by some other mechanism.
Original language | English (US) |
---|---|
Pages (from-to) | 252S-254S |
Journal | CHEST |
Volume | 88 |
Issue number | 4 SUPPL. |
DOIs | |
State | Published - 1985 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine